Achieve Life Sciences Net Income
| ACHV Stock | USD 4.19 0.05 1.18% |
As of the 18th of February 2026, Achieve Life shows the risk adjusted performance of 0.0484, and Mean Deviation of 3.08. Achieve Life Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Achieve Life Sciences variance, as well as the relationship between the value at risk and skewness to decide if Achieve Life Sciences is priced correctly, providing market reflects its regular price of 4.19 per share. Given that Achieve Life has jensen alpha of 0.1158, we suggest you to validate Achieve Life Sciences's prevailing market performance to make sure the company can sustain itself at a future point.
Achieve Life's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Achieve Life's valuation are provided below:Achieve Life Sciences does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. What growth prospects exist in Biotechnology sector? Can Achieve capture new markets? Factors like these will boost the valuation of Achieve Life. If investors know Achieve will grow in the future, the company's valuation will be higher. Valuation analysis balances hard financial data with qualitative growth assessments. While each Achieve Life valuation metric matters, prioritizing which indicators carry greater predictive weight remains essential.
The market value of Achieve Life Sciences is measured differently than its book value, which is the value of Achieve that is recorded on the company's balance sheet. Investors also form their own opinion of Achieve Life's value that differs from its market value or its book value, called intrinsic value, which is Achieve Life's true underlying value. Investment professionals apply varied valuation frameworks to compute inherent worth and acquire positions when market prices trade at discounts to calculated value. Because Achieve Life's market value can be influenced by many factors that don't directly affect Achieve Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Achieve Life's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Achieve Life represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Achieve Life's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Achieve Life 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Achieve Life's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Achieve Life.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Achieve Life on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Achieve Life Sciences or generate 0.0% return on investment in Achieve Life over 90 days. Achieve Life is related to or competes with Entrada Therapeutics, Vanda Pharmaceuticals, Humacyte, Voyager Therapeutics, Atea Pharmaceuticals, Arcturus Therapeutics, and Allogene Therapeutics. Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for s... More
Achieve Life Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Achieve Life's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Achieve Life Sciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.94 | |||
| Information Ratio | 0.0398 | |||
| Maximum Drawdown | 25.05 | |||
| Value At Risk | (5.83) | |||
| Potential Upside | 5.86 |
Achieve Life Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Achieve Life's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Achieve Life's standard deviation. In reality, there are many statistical measures that can use Achieve Life historical prices to predict the future Achieve Life's volatility.| Risk Adjusted Performance | 0.0484 | |||
| Jensen Alpha | 0.1158 | |||
| Total Risk Alpha | 0.0094 | |||
| Sortino Ratio | 0.042 | |||
| Treynor Ratio | 0.0859 |
Achieve Life February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0484 | |||
| Market Risk Adjusted Performance | 0.0959 | |||
| Mean Deviation | 3.08 | |||
| Semi Deviation | 3.77 | |||
| Downside Deviation | 3.94 | |||
| Coefficient Of Variation | 1961.39 | |||
| Standard Deviation | 4.16 | |||
| Variance | 17.28 | |||
| Information Ratio | 0.0398 | |||
| Jensen Alpha | 0.1158 | |||
| Total Risk Alpha | 0.0094 | |||
| Sortino Ratio | 0.042 | |||
| Treynor Ratio | 0.0859 | |||
| Maximum Drawdown | 25.05 | |||
| Value At Risk | (5.83) | |||
| Potential Upside | 5.86 | |||
| Downside Variance | 15.49 | |||
| Semi Variance | 14.21 | |||
| Expected Short fall | (3.29) | |||
| Skewness | 0.5914 | |||
| Kurtosis | 2.4 |
Achieve Life Sciences Backtested Returns
Achieve Life appears to be slightly risky, given 3 months investment horizon. Achieve Life Sciences secures Sharpe Ratio (or Efficiency) of 0.051, which signifies that the company had a 0.051 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Achieve Life Sciences, which you can use to evaluate the volatility of the firm. Please makes use of Achieve Life's risk adjusted performance of 0.0484, and Mean Deviation of 3.08 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Achieve Life holds a performance score of 4. The firm shows a Beta (market volatility) of 2.35, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Achieve Life will likely underperform. Please check Achieve Life's value at risk, and the relationship between the jensen alpha and skewness , to make a quick decision on whether Achieve Life's price patterns will revert.
Auto-correlation | 0.13 |
Insignificant predictability
Achieve Life Sciences has insignificant predictability. Overlapping area represents the amount of predictability between Achieve Life time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Achieve Life Sciences price movement. The serial correlation of 0.13 indicates that less than 13.0% of current Achieve Life price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.13 | |
| Spearman Rank Test | 0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.39 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Achieve Life Sciences reported net income of (39.83 Million). This is 111.67% lower than that of the Biotechnology sector and 156.86% lower than that of the Health Care industry. The net income for all United States stocks is 106.98% higher than that of the company.
Achieve Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Achieve Life's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Achieve Life could also be used in its relative valuation, which is a method of valuing Achieve Life by comparing valuation metrics of similar companies.Achieve Life is currently under evaluation in net income category among its peers.
Achieve Fundamentals
| Return On Equity | -1.61 | ||||
| Return On Asset | -0.65 | ||||
| Current Valuation | 185.43 M | ||||
| Shares Outstanding | 53.23 M | ||||
| Shares Owned By Insiders | 4.36 % | ||||
| Shares Owned By Institutions | 43.16 % | ||||
| Number Of Shares Shorted | 6.82 M | ||||
| Price To Earning | (0.03) X | ||||
| Price To Book | 6.64 X | ||||
| EBITDA | (37.42 M) | ||||
| Net Income | (39.83 M) | ||||
| Cash And Equivalents | 29.38 M | ||||
| Cash Per Share | 3.03 X | ||||
| Total Debt | 9.96 M | ||||
| Debt To Equity | 1.18 % | ||||
| Current Ratio | 5.81 X | ||||
| Book Value Per Share | 0.64 X | ||||
| Cash Flow From Operations | (29.77 M) | ||||
| Short Ratio | 7.50 X | ||||
| Earnings Per Share | (1.35) X | ||||
| Target Price | 15.38 | ||||
| Number Of Employees | 25 | ||||
| Beta | 1.84 | ||||
| Market Capitalization | 223.58 M | ||||
| Total Asset | 38.63 M | ||||
| Retained Earnings | (205.58 M) | ||||
| Working Capital | 29.79 M | ||||
| Current Asset | 22.54 M | ||||
| Current Liabilities | 9.1 M | ||||
| Net Asset | 38.63 M |
About Achieve Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Achieve Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Achieve Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Achieve Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Achieve Stock Analysis
When running Achieve Life's price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.